GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » Valuation Rank

Wuxi AppTec Co (SHSE:603259) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Wuxi AppTec Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuxi AppTec Co (SHSE:603259) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » Valuation Rank
Comparable Companies
SZSE:300347 SHSE:603882 SZSE:300676 SHSE:603127 SZSE:300244 SHSE:603108 SZSE:300406 SZSE:300463 SZSE:300685 SZSE:300396 TMO DHR IDXX IQV A XSWX:LONN MTD ICLR ILMN LH
Traded in Other Exchanges
WUXIF:USA WUXAY:USA 02359:Hong Kong WX8:Germany
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131
Website
https://www.wuxiapptec.com
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.